Phase 2
Completed N=110
Cognitive Remediation for Cocaine Dependence
Cocaine Dependence
Source: ClinicalTrials.gov NCT01393457 ↗
Enrolled (actual)
110
Serious AEs
3.6%
Results posted
Mar 2018
Primary outcomePrimary: Cocaine Use Based on Urine Drug Screening — 20.36; 15.57; 22.3; 27.8 number of negative drug screens
Summary
The purpose of this study is to evaluate treatments designed to improve cocaine treatment success by combining medications that target cocaine-related cognitive impairments.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cocaine Use Based on Urine Drug Screening |
20.36; 15.57; 22.3; 27.8 | — |
| SECONDARY Number of Participants Who Completed the 10 Week Trial |
14; 14; 16; 15 | — |
Eligibility Criteria
Inclusion Criteria
- meet criteria for cocaine dependence
- seeking treatment for cocaine dependence
- be in acceptable health based on medical history and physical exam
Exclusion Criteria
- dependent on drugs other than cocaine, nicotine, marijuana
- have a medical condition contraindicating treatment with study medications
- having conditions of probation or parole requiring reports of drug use to officers of the court
Data sourced from ClinicalTrials.gov (NCT01393457). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.